Medtronic is set to strengthen its biologics business with the acquisition of regenerative healing specialist Osteotech in a deal worth $123m. The deal will see Medtronic broaden the range of products it offers in the field of bone healing. Osteotech (Eatontown, New Jersey) sells the ...
Please Login to read the full article.
